Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model

Radiology

Volumn 237, Issue 1, 2005, Pages 144-150

  Kan, Zuxing ^a   Kobayashi, Satoshi ^a   Phongkitkarun, Sith ^a   Charnsangavej, Chusilp ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYVINYL ALCOHOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD VOLUME; BREAST TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; LIVER TUMOR; MEASUREMENT; MOUSE; NONHUMAN; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SURFACE PROPERTY; TUMOR BLOOD FLOW; VALIDATION PROCESS;

ANIMALS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; FEMALE; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 25144463468     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2371040526     Document Type: Article

References (38)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
2. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepatocholangiocarcinoma variants. J Gastroenterol Hepatol 2002;17:401-405.
3. Chuang VP, Wallace S. Current status of transcatheter management of neoplasms. Cardiovasc Intervent Radiol 1980;3:256-267.
4. Wallace S, Ajani JA, Charnsangavej C, et al. Carcinoid tumors: imaging procedures and interventional radiology. World J Surg 1996;20:147-156.
5. Venook AP. Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol 1999;11:38-44.
6. Wallace S, Kan Z, Li C. Hepatic chemoembolization: clinical and experimental correlation. Acta Gastroenterol Belg 2000;63:169-173.
7. Cheng Y, Kan Z, Chen C, et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 2000;24:844-850.
8. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47-54.
9. Soulen MC. Chemoembolization of hepatic malignancies. Oncology (Huntingt) 1994;8:77-84.
10. Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261.
11. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-486.
12. Lee TY. Functional CT: physiological models. Trends Biotechnol 2002;20(12 suppl): S3-S10.
13. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003;76:220-231.
14. Miles KA, Charnsangavej C, Lee FT, Fishman EK, Horton K, Lee TY. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7:840-850.
15. Miles KA. Functional computed tomography in oncology. Eur J Cancer 2002;38:2079-2084.
16. Platt JF, Francis IR, Ellis JH, Reige KA. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology 1997;205:49-53.
17. Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 1998; 71:276-281.
18. Neri A, Welch D, Kawaguchi T, Nicolson GL. Development and biological properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 1982;68:507-517.
19. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30:969-977.
20. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic tumors. Radiology 1993;187:621-626.
21. Kamel IR, Bluemke DA. Imaging evaluation of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13(9 pt 2):S173-S184.
22. Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology 1998;27:1743-1744.
23. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442.
24. Vogl TJ, Trapp M, Schroeder H, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000;214:349-357.
25. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model. Cancer 1991;68:2150-2154.
26. Ernst O, Sergent G, Mizrahi D, Delemazure O, Paris JC, L'Hermine C. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 1999;172:59-64.
27. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroiadiol 1999;20:63-73.
28. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462-470.
29. Eastwood JD, Lev MH, Azhari T, et al. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 2002;222:227-236.
30. Nabavi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999;213:141-149.
31. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46:3161-3175.
32. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Isreal MA, Liotta LA, eds. The molecular basis of cancer. Philadelphia, Pa: Saunders, 1995; 206-232.
33. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
34. Marme D. Tumor angiogenesis: the pivotal role of vascular endothelial growth factor. World J Urol 1996;14:166-174.
35. Bloemendal HJ, Logtenberg T, Voest EE. New strategy in anti-vascular cancer therapy. Eur J Clin Invest 1999;29:802-809.
36. Jain RK. Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-989.
37. Kan Z, Phongkitkarun S, Kobayashi S, Faria S, Hess KR, Charnsangavej C. Functional CT quantification of tumor microciiculation in antiangiogenic therapy (abstr). Radiology 2002; 225(P):47.
38. Phongkitkarun S, Kan Z, Kobayashi S, et al. Vascular permeability of a murine mammary tumor model assessed by functional CT using low- and high-molecular weight contrast media (abstr). In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2003; 335.